First Follow-Up of Cardiac Amyloidosis Treated by Tafamidis, Evaluated by Absolute Quantification in Bone Scintigraphy

Assessment of absolute myocardial hydroxydimethylene diphosphonate–technetium-99m uptake using standardized uptake value with a single-photon emission computed tomography–computed tomography cadmium zinc telluride camera (Discovery NM/CT 670CZT, GE Healthcare, Chicago, Illinois) in a patient with ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Bellevre, Dimitri, Bailliez, Alban, Maréchaux, Sylvestre, Manrique, Alain, Mouquet, Frédéric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Mini-Focus Issue: Imaging
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8305621/
https://www.ncbi.nlm.nih.gov/pubmed/34317486
http://dx.doi.org/10.1016/j.jaccas.2020.11.036
_version_ 1783727617245970432
author Bellevre, Dimitri
Bailliez, Alban
Maréchaux, Sylvestre
Manrique, Alain
Mouquet, Frédéric
author_facet Bellevre, Dimitri
Bailliez, Alban
Maréchaux, Sylvestre
Manrique, Alain
Mouquet, Frédéric
author_sort Bellevre, Dimitri
collection PubMed
description Assessment of absolute myocardial hydroxydimethylene diphosphonate–technetium-99m uptake using standardized uptake value with a single-photon emission computed tomography–computed tomography cadmium zinc telluride camera (Discovery NM/CT 670CZT, GE Healthcare, Chicago, Illinois) in a patient with cardiac transthyretin-related amyloidosis treated with tafamidis showed a decrease in hydroxydimethylene diphosphonate cardiac uptake. This imaging technique should be helpful in monitoring therapy and evaluating prognosis. (Level of Difficulty: Intermediate.)
format Online
Article
Text
id pubmed-8305621
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-83056212021-07-26 First Follow-Up of Cardiac Amyloidosis Treated by Tafamidis, Evaluated by Absolute Quantification in Bone Scintigraphy Bellevre, Dimitri Bailliez, Alban Maréchaux, Sylvestre Manrique, Alain Mouquet, Frédéric JACC Case Rep Mini-Focus Issue: Imaging Assessment of absolute myocardial hydroxydimethylene diphosphonate–technetium-99m uptake using standardized uptake value with a single-photon emission computed tomography–computed tomography cadmium zinc telluride camera (Discovery NM/CT 670CZT, GE Healthcare, Chicago, Illinois) in a patient with cardiac transthyretin-related amyloidosis treated with tafamidis showed a decrease in hydroxydimethylene diphosphonate cardiac uptake. This imaging technique should be helpful in monitoring therapy and evaluating prognosis. (Level of Difficulty: Intermediate.) Elsevier 2021-01-20 /pmc/articles/PMC8305621/ /pubmed/34317486 http://dx.doi.org/10.1016/j.jaccas.2020.11.036 Text en © 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Mini-Focus Issue: Imaging
Bellevre, Dimitri
Bailliez, Alban
Maréchaux, Sylvestre
Manrique, Alain
Mouquet, Frédéric
First Follow-Up of Cardiac Amyloidosis Treated by Tafamidis, Evaluated by Absolute Quantification in Bone Scintigraphy
title First Follow-Up of Cardiac Amyloidosis Treated by Tafamidis, Evaluated by Absolute Quantification in Bone Scintigraphy
title_full First Follow-Up of Cardiac Amyloidosis Treated by Tafamidis, Evaluated by Absolute Quantification in Bone Scintigraphy
title_fullStr First Follow-Up of Cardiac Amyloidosis Treated by Tafamidis, Evaluated by Absolute Quantification in Bone Scintigraphy
title_full_unstemmed First Follow-Up of Cardiac Amyloidosis Treated by Tafamidis, Evaluated by Absolute Quantification in Bone Scintigraphy
title_short First Follow-Up of Cardiac Amyloidosis Treated by Tafamidis, Evaluated by Absolute Quantification in Bone Scintigraphy
title_sort first follow-up of cardiac amyloidosis treated by tafamidis, evaluated by absolute quantification in bone scintigraphy
topic Mini-Focus Issue: Imaging
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8305621/
https://www.ncbi.nlm.nih.gov/pubmed/34317486
http://dx.doi.org/10.1016/j.jaccas.2020.11.036
work_keys_str_mv AT bellevredimitri firstfollowupofcardiacamyloidosistreatedbytafamidisevaluatedbyabsolutequantificationinbonescintigraphy
AT bailliezalban firstfollowupofcardiacamyloidosistreatedbytafamidisevaluatedbyabsolutequantificationinbonescintigraphy
AT marechauxsylvestre firstfollowupofcardiacamyloidosistreatedbytafamidisevaluatedbyabsolutequantificationinbonescintigraphy
AT manriquealain firstfollowupofcardiacamyloidosistreatedbytafamidisevaluatedbyabsolutequantificationinbonescintigraphy
AT mouquetfrederic firstfollowupofcardiacamyloidosistreatedbytafamidisevaluatedbyabsolutequantificationinbonescintigraphy

Ejemplares similares